Total raised
—
Last: Undisclosed 2024-01
Stage
Seed
Founded
2024
Headcount
6
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
TenAces Biosciences is a biopharmaceutical company focused on the development of molecular glue therapeutics. The molecular glues are small molecules that can induce or stabilize the interaction between an E3 ligase and a target protein. This enhanced binding accelerates the tagging with ubiquitin, and subsequent removal of the target protein by the proteasome.
The company's approach, based on machine learning, 3D modeling and virtual compound screening, allows for the development of rationally designed molecular glues for a wide range of diseases.
Funding history · 1 round · — total
2024-01
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is TenAces Biosciences' primary focus?
- TenAces Biosciences is a biopharmaceutical company focused on the development of molecular glue therapeutics.
- When was TenAces Biosciences founded?
- TenAces Biosciences was founded in January 2024.
- Where is TenAces Biosciences headquartered?
- TenAces Biosciences is headquartered in Rehovot, Israel.
- What is the core technology used by TenAces Biosciences for drug discovery?
- TenAces Biosciences utilizes machine learning, 3D modeling, and virtual compound screening for the development of rationally designed molecular glues.
- Which investors participated in TenAces Biosciences' undisclosed funding round in January 2024?
- In January 2024, TenAces Biosciences received funding from AION Labs and Israel Biotech Fund in an undisclosed round.
- What is the current employee count for TenAces Biosciences?
- TenAces Biosciences currently has 6 employees.
- What is the primary sector of TenAces Biosciences?
- TenAces Biosciences operates in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Who is a co-founder of TenAces Biosciences?
- Arnout Schepers is a co-founder of TenAces Biosciences.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine LearningBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
machine-learningpharmaceuticalscell-therapybiopharmaceutical